Bernhard C. Pestalozzi

7.2k total citations
107 papers, 4.6k citations indexed

About

Bernhard C. Pestalozzi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Bernhard C. Pestalozzi has authored 107 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 20 papers in Surgery. Recurrent topics in Bernhard C. Pestalozzi's work include Pancreatic and Hepatic Oncology Research (19 papers), HER2/EGFR in Cancer Research (18 papers) and Colorectal Cancer Treatments and Studies (16 papers). Bernhard C. Pestalozzi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (19 papers), HER2/EGFR in Cancer Research (18 papers) and Colorectal Cancer Treatments and Studies (16 papers). Bernhard C. Pestalozzi collaborates with scholars based in Switzerland, United States and Germany. Bernhard C. Pestalozzi's co-authors include Pierre–Alain Clavien, Achim Weber, Aron Goldhirsch, Stefan Heinrich, Monica Castiglione‐Gertsch, Thomas F. Hany, Richard D. Gelber, Richard Herrmann, Elizabeth Murray and Karen N. Price and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Bernhard C. Pestalozzi

106 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernhard C. Pestalozzi Switzerland	35	2.9k	1.7k	1.1k	992	669	107	4.6k
A. Laplanche France	31	2.7k 0.9×	1.9k 1.2×	1.1k 1.0×	531 0.5×	497 0.7×	82	4.6k
Changhoon Yoo South Korea	34	2.5k 0.9×	1.4k 0.9×	1.4k 1.2×	537 0.5×	785 1.2×	252	4.2k
John F. Gibbs United States	39	2.1k 0.7×	1.6k 0.9×	1.9k 1.8×	555 0.6×	829 1.2×	150	4.7k
Per Pfeiffer Denmark	45	3.9k 1.4×	1.8k 1.1×	1.9k 1.7×	1.2k 1.2×	427 0.6×	302	6.3k
Ashley E. Winkler United States	10	3.9k 1.4×	2.5k 1.5×	1.4k 1.3×	848 0.9×	731 1.1×	12	7.3k
Caroline Caramella France	31	4.6k 1.6×	2.2k 1.3×	1.2k 1.1×	1.1k 1.1×	969 1.4×	137	6.3k
Gabriele Luppi Italy	28	3.4k 1.2×	1.3k 0.8×	1.7k 1.5×	398 0.4×	794 1.2×	105	4.3k
Stefan Boeck Germany	36	3.4k 1.2×	1.2k 0.7×	890 0.8×	1.2k 1.2×	852 1.3×	145	4.3k
Mitchell C. Posner United States	43	2.9k 1.0×	2.5k 1.5×	2.3k 2.1×	856 0.9×	621 0.9×	175	6.4k
F. Huguet France	28	2.8k 1.0×	1.7k 1.0×	1.6k 1.4×	1.0k 1.0×	909 1.4×	168	4.3k

Countries citing papers authored by Bernhard C. Pestalozzi

Since Specialization

Citations

This map shows the geographic impact of Bernhard C. Pestalozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard C. Pestalozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard C. Pestalozzi more than expected).

Fields of papers citing papers by Bernhard C. Pestalozzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard C. Pestalozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard C. Pestalozzi. The network helps show where Bernhard C. Pestalozzi may publish in the future.

Co-authorship network of co-authors of Bernhard C. Pestalozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard C. Pestalozzi. A scholar is included among the top collaborators of Bernhard C. Pestalozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard C. Pestalozzi. Bernhard C. Pestalozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seiler, Annina, Caroline Hertler, Sebastian M. Christ, et al.. (2024). Effects of dignity therapy on psychological distress and wellbeing of palliative care patients and family caregivers – a randomized controlled study. BMC Palliative Care. 23(1). 73–73. 14 indexed citations

Zoche, Martin, Bernhard C. Pestalozzi, Isabell Witzel, et al.. (2024). ERBB2‐amplified lobular breast carcinoma exhibits concomitant CDK12 co‐amplification associated with poor prognostic features. The Journal of Pathology Clinical Research. 10(2). e12362–e12362. 3 indexed citations

Papassotiropoulos, Bärbel, Constanze Elfgen, Konstantin J. Dedes, et al.. (2022). Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy. Scientific Reports. 12(1). 91–91. 12 indexed citations

Schmid, Sabine, Dirk Klingbiel, Stefan Aebi, et al.. (2019). Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data. BMC Cancer. 19(1). 902–902. 7 indexed citations

Bernatz, Simon, Elena I. Ilina, Kavi Devraj, et al.. (2019). Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastases. Journal of Experimental & Clinical Cancer Research. 38(1). 434–434. 13 indexed citations

Rechsteiner, Markus, Konstantin J. Dedes, Daniel Fink, et al.. (2018). Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features. Journal of Cancer Research and Clinical Oncology. 144(5). 865–874. 6 indexed citations

Pestalozzi, Bernhard C., et al.. (2016). Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital. Swiss Medical Weekly. 146(5152). w14393–w14393. 2 indexed citations

Kasenda, Benjamin, Dieter Koeberle, Bernhard C. Pestalozzi, et al.. (2014). Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study. BMC Cancer. 14(1). 728–728. 37 indexed citations

Pestalozzi, Bernhard C., Eileen Holmes, Evandro de Azambuja, et al.. (2013). CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01). The Lancet Oncology. 14(3). 244–248. 142 indexed citations

10.

Hoff, Paulo M., Andreas Hochhaus, Bernhard C. Pestalozzi, et al.. (2012). Cediranib Plus FOLFOX/CAPOX Versus Placebo Plus FOLFOX/CAPOX in Patients With Previously Untreated Metastatic Colorectal Cancer: A Randomized, Double-Blind, Phase III Study (HORIZON II). Journal of Clinical Oncology. 30(29). 3596–3603. 112 indexed citations

11.

Zardavas, Dimitrios, Alexander Meisel, Panagiotis Samaras, et al.. (2011). Temsirolimus Is Highly Effective as Third-Line Treatment in Chromophobe Renal Cell Cancer. SHILAP Revista de lepidopterología. 4(1). 16–18. 15 indexed citations

12.

Probst‐Hensch, Nicole, Peter Schraml, Zsuzsanna Varga, et al.. (2010). IGFBP2 and IGFBP3 Protein Expressions in Human Breast Cancer: Association with Hormonal Factors and Obesity. Clinical Cancer Research. 16(3). 1025–1032. 55 indexed citations

13.

Dedes, Konstantin J., Klazien Matter‐Walstra, Matthias Schwenkglenks, et al.. (2009). Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation. European Journal of Cancer. 45(8). 1397–1406. 56 indexed citations

14.

Riener, Marc‐Oliver, Frank Stenner, Heike Liewen, et al.. (2009). Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas #. Hepatology. 49(5). 1602–1609. 108 indexed citations

15.

Samaras, Panagiotis, Stefan Dold, Julia Braun, et al.. (2008). Infectious Port Complications Are More Frequent in Younger Patients with Hematologic Malignancies than in Solid Tumor Patients. Oncology. 74(3-4). 237–244. 56 indexed citations

16.

Theurillat, Jean‐Philippe, Ursina Zürrer‐Härdi, Zsuzsanna Varga, et al.. (2007). NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy. Cancer Immunology Immunotherapy. 56(11). 1723–1731. 38 indexed citations

17.

Schaefer, Niklaus, Bernhard C. Pestalozzi, Alexander Knuth, & Christoph Renner. (2006). Potential use of humanized antibodies in the treatment of breast cancer. Expert Review of Anticancer Therapy. 6(7). 1065–1074. 14 indexed citations

18.

Pestalozzi, Bernhard C., et al.. (2005). ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Annals of Oncology. 16. i7–i9. 57 indexed citations

19.

Varga, Zsuzsanna, Rosmarie Caduff, & Bernhard C. Pestalozzi. (2005). Stability of the HER2 gene after primary chemotherapy in advanced breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 446(2). 136–141. 43 indexed citations

20.

Urosevic, Mirjana, et al.. (2005). Successful imiquimod treatment of multiple basal cell carcinomas after radiation therapy for Hodgkin's disease.. PubMed. 15(1). 52–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact